154 related articles for article (PubMed ID: 4361409)
1. Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma.
Hofeldt FD; Dippe SE; Levin SR; Karam JH; Blum MR; Forsham PH
Diabetes; 1974 Mar; 23(3):192-8. PubMed ID: 4361409
[No Abstract] [Full Text] [Related]
2. Hormonal responses to intravenous and oral glucose tolerance testing in a patient with a gastrinoma and a gastrojejunostomy.
Massaro RP
Gastroenterology; 1974 May; 66(5):1058-62. PubMed ID: 4363772
[No Abstract] [Full Text] [Related]
3. [Zollinger-Ellison syndrome and metastatic insulinoma; its response to streptozotocin].
Agular-Parada E; Rivadeneyra-Hinojosa J; Guzman-Patraca C; Salas-Montero J; Escalante-Herrera A
Arch Invest Med (Mex); 1977; 8(1):31-8. PubMed ID: 192163
[TBL] [Abstract][Full Text] [Related]
4. Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.
Ellison EC; O'Dorisio TM; Benson GD
Am J Surg; 1986 Jun; 151(6):668-75. PubMed ID: 2872829
[No Abstract] [Full Text] [Related]
5. Medical treatment for inoperable insulinoma: clinical usefulness of diphenylhydantoin and diltiazem.
Imanaka S; Matsuda S; Ito K; Matsuoka T; Okada Y
Jpn J Clin Oncol; 1986 Mar; 16(1):65-71. PubMed ID: 3009920
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of insulin release by diphenylhydantoin and diazoxide in a patient with benign insulinoma.
Cohen MS; Bower RH; Fidler SM; Johnsonbaugh RE; Sode J
Lancet; 1973 Jan; 1(7793):40-1. PubMed ID: 4118560
[No Abstract] [Full Text] [Related]
7. [Effect of propranolol on the blood sugar immunoreactive blood insulin in a patient with insulinoma].
Neri V; Bartorelli A; Faglia G
Acta Diabetol Lat; 1969; 6(4):809-19. PubMed ID: 4321785
[No Abstract] [Full Text] [Related]
8. Editorial: Streptozotocin for islet-cell carcinoma.
Lancet; 1973 Nov; 2(7837):1063-4. PubMed ID: 4127316
[No Abstract] [Full Text] [Related]
9. Qualitative abnormality of insulin secretion in a case with insulinoma.
Harano Y; Kohama M; Araki N; Sakamoto A; Hoshi M
Endocrinol Jpn; 1975 Apr; 22(2):175-80. PubMed ID: 168060
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma.
Curnow RT; Carey RM; Taylor A; Johanson A; Murad F
N Engl J Med; 1975 Jun; 292(26):1385-6. PubMed ID: 166308
[No Abstract] [Full Text] [Related]
11. Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis.
Vance JE; Stoll RW; Kitabchi AE; Buchanan KD; Hollander D; Williams RH
Am J Med; 1972 Feb; 52(2):211-27. PubMed ID: 4400504
[No Abstract] [Full Text] [Related]
12. Common origin for all neuroendocrine tumors.
Gammill SL; Weichert R
Acta Radiol Ther Phys Biol; 1973 Aug; 12(4):321-6. PubMed ID: 4147974
[No Abstract] [Full Text] [Related]
13. Carcinoid-islet cell tumors.
Gammill SL; Weichert R; Smith SL; Font R; Ingraffia R
Acta Radiol Ther Phys Biol; 1973 Jun; 12(3):229-40. PubMed ID: 4356093
[No Abstract] [Full Text] [Related]
14. Defective regulation of insulin secretion in diabetes and insulinoma.
Flatt PR
Biochem Soc Trans; 1990 Feb; 18(1):124-7. PubMed ID: 2158914
[No Abstract] [Full Text] [Related]
15. Insulin and ACTH production by a streptozotocin responsive islet cell carcinoma.
Walter RM; Ensinck JW; Ricketts H; Kendall JW; Williams RH
Am J Med; 1973 Nov; 55(5):667-70. PubMed ID: 4356098
[No Abstract] [Full Text] [Related]
16. Effect of diphenylhydantoin on insulin secretion in man.
Malherbe C; Burrill KC; Levin SR; Karam JH; Forsham PH
N Engl J Med; 1972 Feb; 286(7):339-42. PubMed ID: 5008555
[No Abstract] [Full Text] [Related]
17. Insulin and growth hormone regulation in organic hyperinsulinism.
AvRuskin TW; Coran AG; Crigler JF
Surg Gynecol Obstet; 1971 Jul; 133(1):1-10. PubMed ID: 4326382
[No Abstract] [Full Text] [Related]
18. Exaggerated intestinal glucagon and insulin responses in human subjects.
Vance JE; Stoll RW; Fariss BL; Williams RH
Metabolism; 1972 May; 21(5):405-12. PubMed ID: 4401389
[No Abstract] [Full Text] [Related]
19. Anesthesia for patients with insulinoma treatment with oral diazoxide.
Burch PG; McLeskey CH
Anesthesiology; 1981 Oct; 55(4):472-5. PubMed ID: 6271026
[No Abstract] [Full Text] [Related]
20. Metabolic effects of diazoxide in normal subjects, patients with diabetes mellitus, and patients with organic hypoglycemia.
Steinke J; Soeldner JS
Ann N Y Acad Sci; 1968 Apr; 150(2):326-36. PubMed ID: 4299223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
